DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Glufosfamide is an investigational drug.
There have been 9 clinical trials for Glufosfamide. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2004.
The most common disease conditions in clinical trials are Pancreatic Neoplasms, Lung Neoplasms, and Carcinoma, Small Cell. The leading clinical trial sponsors are Threshold Pharmaceuticals, European Organisation for Research and Treatment of Cancer - EORTC, and Eleison Pharmaceuticals LLC.
Recent Clinical Trials for Glufosfamide
|Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer||Eleison Pharmaceuticals LLC.||Phase 3|
|Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma||Threshold Pharmaceuticals||Phase 2|
|Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma||Eleison Pharmaceuticals LLC.||Phase 2|